The Hypothesis: Spatial Scaffolding as a Translational Rheostat

I suspect the tissue-specific dichotomy of 4E-BP1—where it protects skeletal muscle but promotes skin cancer—isn't just a matter of protein abundance. Instead, it’s dictated by the spatial recruitment of the deubiquitinase USP37 to the mTORC1-Raptor complex. In this model, the USP37-Raptor axis acts as a "Stoichiometric Shield." In tissues like skeletal muscle, localized USP37 likely stabilizes Raptor at the plasma membrane. This restricts mTORC1 activity to a specific subset of mTORC1-Raptor-4E-BP1 complexes that prioritize PGC-1α translation over global protein synthesis. In contrast, in cancer-prone tissues, the dissociation of this complex leads to 4E-BP1 hyper-phosphorylation, fueling the unchecked cap-dependent translation of oncogenic drivers.

Mechanistic Reasoning

Current models treat 4E-BP1 as a simple binary switch, toggling "on" or "off" based on mTORC1 status. Yet, evidence shows that 4E-BP1 selectively regulates specific mRNA subsets—balancing metabolic homeostasis against proliferation—which suggests we need a spatial explanation for its function 4E-BP1 differentially regulates translation of mRNA subsets.

I posit that USP37 is the missing variable in the translation-aging nexus. By deubiquitinating Raptor, USP37 maintains a high local concentration of 4E-BP1 in the perinuclear space. This confinement forces 4E-BP1 to preferentially interact with specific subsets of 43S pre-initiation complexes. When this tether is lost—common in aging or oncogenesis—the 4E-BP1 pool becomes diffuse and phosphorylated, losing its specificity and reverting to a blunt, global repressor Loss of 4E-BP1 promotes skin carcinogenesis.

Predictions for Aging Interventions

1. Targeted DUB Activation: I predict that activating the USP37-Raptor axis in the aging brain will restore 4E-BP1-mediated repression of pro-inflammatory cytokines like TNFα and IL-1β, all while preserving high-fidelity translation of synaptic transcripts Cap-dependent translation decline drives neuroinflammation in aging.
2. Differential Sensitivity: mTORC1 inhibition in muscle is often hindered by systemic side effects. By selectively stabilizing the USP37-4E-BP1 axis, we could achieve metabolic rejuvenation via PGC-1α/FGF21 without the collateral damage caused by global mTORC1 blockade Muscle-specific 4E-BP1 activation improves metabolic parameters during aging and obesity.

Falsifiability

This hypothesis can be tested through:

• Proximity Ligation Assays (PLA): To see if USP37-Raptor-4E-BP1 complexes occupy distinct spatial niches in muscle versus skin.
• CRISPR-mediated truncation: If we mutate the USP37-binding domain of Raptor, the protective metabolic benefits of 4E-BP1 in skeletal muscle should disappear, even if total 4E-BP1 levels remain unchanged.

By framing 4E-BP1 as a spatial filter rather than a global switch, we can work toward a precision approach for aging. We don't need to shut down cellular survival signaling; we just need to tune the translation profiles of specific tissues to ward off inflammation and metabolic collapse.

Ongoing Threads: "The eIF3d Bypass Hypothesis: Tissue-Specific Stoichiometry Dictates 4E-BP1 Selective mRNA Translation in Aging"